Nu Skin Entreprises, Inc. has announced estimated revenue and earnings per share figures for Q2 2013.
Having significantly increased on prior revenue guidance, revenue is now estimated to total approximately $680m, while earnings per share are predicted to total roughly $1.20. Foreign currency fluctuations negatively impacted Q2 revenue by approximately 3%.
Truman Hunt, President and Chief Executive Officer, said: “Our second quarter results reflect the strong momentum of our business. After a record 2012 that included impressive ageLOC product launches in the second quarter, we continue to generate healthy gains throughout our global business, particularly in the Greater China, North Asia and Americas regions.
“We look forward to sharing full second quarter results with our shareholders on 1 August during our quarterly conference call. In addition, we will provide updates on our expectations for the remainder of the year, which include the limited time introduction of our new ageLOC TR90 weight management system in September and October. We continue to expect this product introduction to be the largest in our history and anticipate a net impact of approximately $380 to $400m from TR90 sales in the second half of the year.”
Nu Skin has also announced that its full year 2013 revenue guidance is to increase by $320m to $286bn, while 2013 earnings per share are valued at $4.85-$5.
